Literature DB >> 17873184

Transition from IV to subcutaneous prostacyclin: premature withdrawal?

Shelley Shapiro, Nicholas S Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17873184     DOI： 10.1378/chest.07-1992

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

Review 1.  Systemic sclerosis--challenges for clinical practice.

Authors:  Zsuzsanna H McMahan; Laura K Hummers
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

Review 2.  Transition from intravenous epoprostenol to oral or subcutaneous therapy in pulmonary arterial hypertension: a retrospective case series and systematic review.

Authors:  Kirily Park; David Ostrow; Robert D Levy; John Swiston
Journal:  Can Respir J       Date:  2011 May-Jun       Impact factor: 2.409

Review 3.  New approaches to the treatment of pulmonary hypertension: from bench to bedside.

Authors:  Subramanyam N Murthy; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Mar-Apr       Impact factor: 2.644
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.